Hip Replacement SurgeryNCT06307145
Korea Hip Replacement Surgery Registry
An observational study of Hip Replacement Surgery, run by Samsung Medical Center.
Trial summary
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Hip Replacement Surgery
- How many people
- 124,556 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2003to 31 Dec 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patient aged 19 or older who received hip replacement surgery
Who may be able to join
- Patient aged 19 or older who received hip replacement surgery
Who cannot join
- Insufficient information
- history of any revision
About this study
Official title: Efficacy and Safety of Hip Replacement Surgery Using Korean National Registry
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner.
Read the detailed description
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner. The safety issues included the incidence of cancer, orthoperiodic outcome (dislocation, mechanical Cx, periprosthetic join infection, periprosthetic fracture), revision, embolism or thrombosis, cardiac outcome, and death
- Conditions
- Hip Replacement Surgery
What is being measured
The primary outcome is the main question the study is designed to answer.
Cancer
Incidence of cancer
Measured: the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2024
- Study start1 Jan 2003
- Primary completion31 Dec 2020
- Study completion31 Dec 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Hip Replacement SurgeryStudies of the same condition, open and under way.
- More trials run by Samsung Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 124,556 participants (actual)
Sponsor and investigators
- Lead sponsor
- Samsung Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Juhee Cho, Samsung Medical Center
- Investigators
- Juhee Cho, Principal investigator, Samsung Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06307145
- Sponsor's protocol ID
- K-NHIS-HIP
- Status last verified
- Mar 2024
- First submitted
- 5 Mar 2024
- Last updated
- 12 Mar 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Access to the dataset is limited to researchers who have been approved by the NHIS.
Publications
Park JW, Kang D, Kim H, Kang E, Cho J, Lee YK. Cement Use in Bipolar Hemiarthroplasty and Its Association With Cancer Risk. J Korean Med Sci. 2026 Aug 3;41(30):e196. doi: 10.3346/jkms.2026.41.e196.
PubMed 42549999
Study at a glance
From the registry record, last updated by the sponsor on 12 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy and Safety of Hip Replacement Surgery Using Korean National Registry
- ClinicalTrials.gov ID
- NCT06307145
- Acronym / sponsor ID
- K-NHIS-HIP
- Conditions
- Hip Replacement Surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 124,556 participants (actual)
- Lead sponsor
- Samsung Medical CenterUniversity, hospital or other
- Study start
- 1 Jan 2003 (actual)
- Primary completion
- 31 Dec 2020 (actual)
- Study completion
- 31 Dec 2020 (actual)
- First posted
- 12 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner.
Detailed description
This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner. The safety issues included the incidence of cancer, orthoperiodic outcome (dislocation, mechanical Cx, periprosthetic join infection, periprosthetic fracture), revision, embolism or thrombosis, cardiac outcome, and death
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patient aged 19 or older who received hip replacement surgery
Key inclusion criteria (1 listed)
- Patient aged 19 or older who received hip replacement surgery
Key exclusion criteria (2 listed)
- Insufficient information
- history of any revision
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Cancer
Time frame: the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.
Incidence of cancer
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Mar 2024.
- Derived from this study: PubMed 42549999Park JW, Kang D, Kim H, Kang E, Cho J, Lee YK. Cement Use in Bipolar Hemiarthroplasty and Its Association With Cancer Risk. J Korean Med Sci. 2026 Aug 3;41(30):e196. doi: 10.3346/jkms.2026.41.e196.
- Individual participant dataSharing planned: No. Access to the dataset is limited to researchers who have been approved by the NHIS.
Related trials for Hip Replacement Surgery
Not yet recruitingObservational study
Preoperative Muscle Stiffness, Functional Reserve, and Postoperative Quality of Recovery in Lower Extremity Arthroplasty
Osteoarthritis (Knee / Hip), Sarcopenia
RecruitingObservational study
Tau Pathology in the Brain After Hip or Knee Replacement Surgery
Postoperative Cognitive Dysfunction, Alzheimer Disease
Not yet recruitingObservational study
Carotid Ultrasound for Post-Spinal Anesthesia Hypotension in Elderly Hip Surgery
Hypotension After Spinal Anesthesia
Recruiting
Virtual Reality Therapy to Improve Arthroplasty Outcomes
Surgical, Anxiety
Active, not recruiting
Comparative Study Between the Effects of Deep Versus Moderate Neuromuscular Blockade on Postoperative Recovery and Immune Function in Patients Undergoing Total Hip Replacement Surgery.
Immune Responses, Post Operative Recovery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Juhee Cho principal investigator
Samsung Medical Center
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Replacement Surgery, run by Samsung Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cancer (time frame: the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06307145, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2024.